Analyst Ratings For NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO)
Today, Cann reiterated its Hold rating on NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO).
Some recent analyst ratings include
- 4/17/2018-Cann Reiterated Rating of Hold.
- 2/15/2018-SunTrust Banks Reiterated Rating of Buy .
- 2/14/2018-Oppenheimer was Downgraded by analysts at Oppenheimer from a “Outperform ” rating to a ” Market Perform” rating.
- 2/14/2018-UBS was Downgraded by analysts at UBS from a “Outperform ” rating to a ” Market Perform” rating.
Recent Insider Trading Activity For NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO)
NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO) has insider ownership of 5.43% and institutional ownership of 82.41%.
- On 4/12/2018 Christopher Bowden, Insider, sold 2,000 with an average share price of $85.10 per share and the total transaction amounting to $170,200.00.
- On 4/5/2018 Scott Biller, Insider, sold 3,000 with an average share price of $75.20 per share and the total transaction amounting to $225,600.00.
- On 4/2/2018 David P Schenkein, CEO, sold 13,000 with an average share price of $77.72 per share and the total transaction amounting to $1,010,360.00.
- On 3/22/2018 Steven L Hoerter, Insider, sold 2,050 with an average share price of $84.65 per share and the total transaction amounting to $173,532.50.
- On 3/19/2018 Kaye I Foster-Cheek, Director, sold 6,800 with an average share price of $81.97 per share and the total transaction amounting to $557,396.00.
- On 3/16/2018 David Scadden, Director, bought 200 with an average share price of $83.44 per share and the total transaction amounting to $16,688.00.
- On 3/5/2018 Scott Biller, Insider, sold 3,000 with an average share price of $83.08 per share and the total transaction amounting to $249,240.00.
Recent Trading Activity for NASDAQ:AGIO – Agios Pharmaceuticals (NASDAQ:AGIO)
Shares of NASDAQ:AGIO – Agios Pharmaceuticals closed the previous trading session at 86.31 up +0.29 0.34% with 21665 shares trading hands.